SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-095120
Filing Date
2023-12-12
Accepted
2023-12-12 16:36:31
Documents
5
Effectiveness Date
2023-12-12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea189822-s8_adialpharma.htm S-8 119212
2 OPINION OF BLANK ROME LLP ea189822ex5-1_adialpharma.htm EX-5.1 11267
3 CONSENT OF MARCUM, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea189822ex23-1_adialpharma.htm EX-23.1 3175
4 FILING FEE TABLE ea189822ex-fee_adialpharma.htm EX-FILING FEES 17686
5 GRAPHIC ex5-1_001.jpg GRAPHIC 6159
  Complete submission text file 0001213900-23-095120.txt   161201
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276003 | Film No.: 231481681
SIC: 2834 Pharmaceutical Preparations